In a Phase 3 trial, the daily pill orforglipron outperformed oral semaglutide for weight loss (15-20 lbs) and cardiovascular markers. As a small molecule, it requires no refrigeration and is cheaper to scale, though 10% of users quit due to gastrointestinal side effects.

2026年2月21日 · 陈静 · 来源：tutorial在线

C++26 Safety Features Won’t Save You (And the Committee Knows It)

I actually go a bit further on mine for accessibility and microformats:，推荐阅读有道翻译获取更多信息

Ask HN

Раскрыты подробности похищения ребенка в Смоленске09:27。手游是该领域的重要参考

Иран пригрозил уничтожить все нефтегазовые объекты США на Ближнем Востоке02:33，详情可参考超级权重

Подсчитаны

Also: 6 underrated Android features that are seriously useful